Pagas, Cyril .
HRN: 22-17-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2022
BENZYL PENICILLIN 5MU (VIAL)
11/04/2022
11/11/2022
IV
1.2M Units
Q6hrs
RHD
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes